News
-
-
-
REGULATED PRESS RELEASE
Déclaration des transactions sur actions propres réalisées du 22 juillet 2024 au 26 juillet 2024
Déclaration des transactions sur actions propres réalisées par Lagardère SA du 22 au 26 juillet 2024, conformément à la réglementation. Les détails des opérations sont disponibles sur le site web de Lagardère -
REGULATED PRESS RELEASE
Déclaration hebdomadaire d'opérations effectuées du 22 au 26 juillet 2024
-
REGULATED PRESS RELEASE
Disclosure of transactions in own shares on July 22 to July 26, 2024
-
-
PRESS RELEASE
Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Presentation Annual mRNA-based Therapeutics Summit
Applied DNA Sciences, Inc. will present Linea™ IVT platform at 4th Annual mRNA-based Therapeutics Summit to reduce dsRNA contamination in mRNA production, enabling faster and more efficient workflows -
PRESS RELEASE
Knorr-Bremse Aktiengesellschaft: Knorr-Bremse publishes preliminary results for the second quarter of 2024 and raises guidance
Knorr-Bremse AG publishes preliminary results for Q2 2024, exceeding analysts' expectations, with a strong increase in operating EBIT and free cash flow. Full-year guidance raised due to 'BOOST 2026' strategy -
PRESS RELEASE
EQS-Adhoc: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Publishes Preliminary Financial Figures for the Second Quarter of 2024 and Raises Guidance for 2024
Knorr-Bremse AG raises 2024 guidance based on strong Q2/24 results. Key figures exceed expectations. Increased operating EBIT margin forecasted -